Your institution may have access to this item. Find your institution then sign in to continue.
Title
PRODUCT NEWS.
Abstract
The article offers information on the Opzelura (ruxolitinib) cream for treatment of atopic dermatitis from Incyte Corp. and the Twyneo (tretinoin/benzoyl peroxide) cream for the treatment of acne vulgaris from Sol-Gel Technologies Ltd. which have been approved by U.S. Food and Drug Administration.